CSTA  Vol.9 No.2 , May 2020
Synthesis and Crystal Structure Studies of Mitomycin C Dihydrate
Abstract: The absolute configuration of mitomycin C was determined by X-ray single crystal diffraction (CuKα), and a new crystalline dihydrate of mitomycin C had been prepared. The experiment result provides a definitive answer to the real absolute configuration of mitomycin C and may put an end to the dispute that baffles researchers for decadesAt the same time, some contentious structures about the mitomycin C in American Pharmacopoeia USP36-NF31Chinese pharmacopoeia 2015 edtion and numbers of literatures are marked. The absolute configuration is also verified by 1D (1H and 13C) and 2D (HSQC, HMBC, 1H-1COSY and NOESY) NMR studies indirectly. Powder X-ray diffraction (PXRD) pattern of the mitomycin C dihydrate is similar to that calculated for it, which suggests that the purity of sample is excellent.
Cite this paper: Feng, Y. , Chen, Y. , Ren, Y. , Zhang, H. and Cao, S. (2020) Synthesis and Crystal Structure Studies of Mitomycin C Dihydrate. Crystal Structure Theory and Applications, 9, 13-21. doi: 10.4236/csta.2020.92002.

[1]   Karkos, P.D., Leong, S.C., Sastry, A., Assimakopoulos, A.D. and Swift, A.C. (2011) Evidence-Based Applications of Mitomycin C in the Nose. American Journal of Otolaryngology, 32, 422-425.

[2]   Crooke, S.T. and Bradner, W.T. (1976) Mitomycin C: A Review. Cancer Treatment Reviews, 3, 121-139.

[3]   Fiallo, M.M., Kozlowski, H. and Garnier-Suillerot, A. (2001) Mitomycin Antitumor Compounds. Part 1. CD Studies on Their Molecular Structure. European Journal of Pharmaceutical Sciences, 12, 487-494.

[4]   Stevens, C.L., Taylor, K.G., Munk, M.E., Marshall, W.S., Noll, K., Shah, G.D., Shah, L.G. and Uzu, K. (1965) Chemistry and Structure of Mitomycin C. Journal of Medicinal Chemistry, 8, 1-10.

[5]   Ogawa, K., Nomura, A., Fujiwara, T. and Tomita, K.-I. (1979) Crystal and Molecular Structure of Mitomycin C, an Anticancer Antibiotic. Bulletin of the Chemical Society of Japan, 52, 2334-2338.

[6]   Dowell, J.E. (2003) Mitomycin C Provides Little Additional Benefit in the Treatment of Carcinoma of Unknown Primary Site. Cancer Treatment Reviews, 29, 561-563.

[7]   Warner, D. and Brietzke, S.E. (2008) Mitomycin C and Airway Surgery: How Well Does It Work. Otolaryngology—Head and Neck Surgery, 138, 700-709.

[8]   Bradner, W.T. (2001) Mitomycin C: A Clinical Update. Cancer Treatment Reviews, 27, 35-50.

[9]   Doll, D.C., Weiss, R.B. and Issell, B.F. (1985) Mitomycin: Ten Years after Approval for Marketing. Journal of Clinical Oncology, 3, 276-286.

[10]   Arora, S.K. (1979) Structural Investigations of Mode of Action of Drugs. I. Molecular Structure of Mitomycin C. Life Sciences, 24, 1519-1526.

[11]   Yoda, N. and Hirayama, N. (1993) Structure-Activity Relationships for Mitomycins. Application of the Distance and Charge Analysis Method. Journal of Medicinal Chemistry, 36, 1461-1464.

[12]   Hirayama, N., Arai, H. and Kasai, M. (1996) Structural Studies of Mitomycins. VIII. Mitomycin D Hydrate, C15H18N4O5.1.5H2O. Acta Crystallographica C, 52, 2365-2367.

[13]   Kunz, K.R., Iyengar, B.S., Dorr, R.T., Alberts, D.S. and Remers, W.A. (1991) Structure-Activity Relationships for Mitomycin C and Mitomycin A Analogues. Journal of Medicinal Chemistry, 34, 2281-2286.

[14]   Singh, S., Chang, A., Goff, R.D., Bingman, C.A., Gruschow, S., Sherman, D.H., Phillips, G.N. and Thorson, J.S. (2011) Structural Characterization of the Mitomycin 7-O-Methyltransferase. Proteins, 79, 2181-2188.